[go: up one dir, main page]

ATE179074T1 - Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung - Google Patents

Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung

Info

Publication number
ATE179074T1
ATE179074T1 AT92924282T AT92924282T ATE179074T1 AT E179074 T1 ATE179074 T1 AT E179074T1 AT 92924282 T AT92924282 T AT 92924282T AT 92924282 T AT92924282 T AT 92924282T AT E179074 T1 ATE179074 T1 AT E179074T1
Authority
AT
Austria
Prior art keywords
rgd
compositions
methods
adhesion formation
peptide
Prior art date
Application number
AT92924282T
Other languages
English (en)
Inventor
Gere Stodder Dizerega
Kathleen Elizabeth Rodgers
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Application granted granted Critical
Publication of ATE179074T1 publication Critical patent/ATE179074T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT92924282T 1991-11-07 1992-11-06 Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung ATE179074T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78923191A 1991-11-07 1991-11-07

Publications (1)

Publication Number Publication Date
ATE179074T1 true ATE179074T1 (de) 1999-05-15

Family

ID=25146991

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92924282T ATE179074T1 (de) 1991-11-07 1992-11-06 Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung

Country Status (8)

Country Link
US (1) US5629294A (de)
EP (1) EP0667783B1 (de)
AT (1) ATE179074T1 (de)
AU (1) AU3064892A (de)
DE (1) DE69229004D1 (de)
TW (1) TW269634B (de)
WO (1) WO1993008818A1 (de)
ZA (1) ZA928607B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
DE19529909C2 (de) * 1995-08-15 1998-04-09 Fresenius Ag Wässrige Spüllösung
EP0793965A3 (de) * 1996-02-29 1999-02-24 Tano, Yasuo Prophylaktische/therapeutische Zusammensetzung für Nachstar
JP4234803B2 (ja) * 1997-10-27 2009-03-04 久光製薬株式会社 薬物放出速度が制御された医薬組成物
AU5390699A (en) * 1998-07-24 2000-02-14 Pharmacal Biotechnologies, Inc. Osseous tissue reconstruction system and method
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US6312725B1 (en) 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
AU771328B2 (en) * 1999-06-01 2004-03-18 Vivolution A/S Fibrin sealants providing less inflammatory response and methods using same
AU2001236909A1 (en) * 2000-02-11 2001-08-20 Duke University Method of treating disorders of the eye
EP1894945B1 (de) * 2003-03-28 2009-12-02 FUJIFILM Manufacturing Europe B.V. RGD-angereicherte gelatineähnliche Proteine mit verstärkter Zellbindung
WO2005053683A1 (en) * 2003-11-26 2005-06-16 Duke University A method of preventing or treating glaucoma
KR100974733B1 (ko) 2004-04-28 2010-08-06 안지오디바이스 인터내셔널 게엠베하 가교된 생합성물질을 형성하기 위한 조성물 및 시스템, 및이와 관련된 제조 및 사용 방법
CN101379082A (zh) 2006-01-19 2009-03-04 爱吉恩公司 治疗血管相关疾病的包含肽的药物组合物
US9101581B2 (en) 2008-10-27 2015-08-11 Eyegene Inc. Method for treating vascular-related disease
US20090220463A1 (en) * 2006-01-19 2009-09-03 Doo-Sik Kim Pharmaceutical Composition For Treating Vascular-Related Diseases Comprising Peptide
JP2010539038A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのＴｙｒ−Ｗ−ＭＩＦ−１およびウロコーチン２の使用
US20100204130A1 (en) * 2007-09-11 2010-08-12 Dorian Bevec Use of human neuropeptide as a therapeutic agent
WO2009033711A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
JP2010539067A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのＧｌｙ−Ｐｒｏ−Ｇｌｕ−ＯＨ（ＧＰＥ）の使用
US20110250284A1 (en) * 2008-06-24 2011-10-13 Lavik Erin B Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles
US9555071B2 (en) * 2012-06-13 2017-01-31 Thien Nguyen Methods and compositions for the treatment of axonal and neuronal degeneration

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide
US4661111A (en) * 1982-08-04 1987-04-28 La Jolla Cancer Research Foundation Polypeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4517686A (en) * 1982-08-04 1985-05-21 La Jolla Cancer Research Foundation Polypeptide
US4614517A (en) * 1982-08-04 1986-09-30 La Jolla Cancer Research Foundation Tetrapeptide
US4589881A (en) * 1982-08-04 1986-05-20 La Jolla Cancer Research Foundation Polypeptide
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
EP0275748B1 (de) * 1986-12-15 1992-08-19 Institut National De La Sante Et De La Recherche Medicale (Inserm) Peptid-Derivate und deren Verwendung in der Therapie
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
JPH02240020A (ja) * 1989-01-26 1990-09-25 Childrens Medical Center Corp:The 外科的切除後の腫瘍再発阻止剤
NZ235564A (en) * 1989-10-13 1993-10-26 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical compositions
NZ235563A (en) * 1989-10-13 1993-04-28 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical composition
US5169833A (en) * 1989-12-15 1992-12-08 G. D. Searle & Co. Substituted cyclic pentapeptides

Also Published As

Publication number Publication date
EP0667783A4 (de) 1995-04-25
EP0667783B1 (de) 1999-04-21
ZA928607B (en) 1993-06-07
EP0667783A1 (de) 1995-08-23
AU3064892A (en) 1993-06-07
US5629294A (en) 1997-05-13
DE69229004D1 (de) 1999-05-27
TW269634B (de) 1996-02-01
WO1993008818A1 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
DE69229004D1 (de) Zusammensetzungen und verfahren zur verhinderung der adhäsionbildung
FI945912A0 (fi) Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö
DE69705746D1 (de) Injizierbare depotgelzubereitung und herstellungsverfahren
CA2186126A1 (en) Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
CA2285203A1 (en) Compositions containing capsaicin or capsaicin analogues and a local anesthetic
ATE261278T1 (de) Mikrokapseln zum verabreichen von neuroaktiven wirkstoffen
DK0754034T3 (da) Brusende farmaceutiske formuleringer indeholdende biologisk nedbrydelige mikrokapsler med kontrolleret afgivelse
RU2004111596A (ru) Офтальмические композиции в форме депо для периокулярного или субконъюнктивального введения
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
HK1022091A1 (en) Percutaneous absorption type preparation
ATE141790T1 (de) Medikament zur hemmung der stickoxid-bildung
NO305581B1 (no) Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose
IE61346B1 (en) A permeable material to fit around the teeth or gums of a mammal
ATE171869T1 (de) Film zur lokalen arzneistoffabgabe für periodontale behandlung
ATE161423T1 (de) Verwendung von phosphinate zur behandlung der osteoporose
DE69426530D1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
DE69808938D1 (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
FR2686250B1 (de)
ATE289506T1 (de) Hemmung der tnf-aktivität mit zusammensetzungen enthaltend heparin und lösliche tnf rezeptoren
Carroll et al. The histologic effect of topically applied acetylsalicylic acid on bone healing in rats
BR9804768A (pt) Droga e aplicação de uma mistura
LV12768B (lv) Metode imūnās reakcijas nomākšanai pret terapeitiskām olbaltumvielām
Nawata et al. Bone Regeneration in Femoral Defect Filled with Fibrin Sealant. An Experimental Study
DE69927599D1 (de) Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie
IGARI An experimental study on the bone bridging induced by autogenous iliac bone grafts into artificial maxillary alveolar clefts in dogs The comparison of cordco-cancellous bone block and particulate cancellous bone and marrow

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties